Intrinsic Value of S&P & Nasdaq Contact Us

Aldeyra Therapeutics, Inc. ALDX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
$414,729,000.00
+23169217777.1%
Analyst Price Target
$7.00
+291.1%

Aldeyra Therapeutics, Inc. (ALDX) has 20 known insider and institutional holders on record. The largest holder is EDELMAN JOSEPH with 11,350,085 shares. Other notable holders include PERCEPTIVE ADVISORS LLC and Brady Todd C.

Over the last 12 months, insiders have made 14 transactions in ALDX stock — 12 buys (valued at $338.28K) and 1 sells (valued at $113.71K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ALDX Insider Ownership

Top Holder
EDELMAN JOSEPH
11,350,085 shares
Buys (12 mo)
12
$338.28K value
Sells (12 mo)
1
$113.71K value
12-Month Transaction Activity
Buy 86%
Sell 7%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Edelman Joseph Director 11,350,085 2022-08-11
100%
2 Perceptive Advisors Llc 10 Percent Owner 5,875,851 2025-04-07
52%
3 Brady Todd C President and CEO 632,318 2026-03-31
6%
4 Reed Joshua Chief Financial Officer 250,000 2022-04-01
2%
5 Mcmullin David Chief Commercial Officer 250,000 2020-03-06
2%
6 Machatha Stephen Chief Development Officer 221,799 2025-08-13
2%
7 Douglas Richard Director 195,000 2026-03-20
2%
8 Greenberg Bruce See Remarks 126,382 2024-08-14
1%
9 Clark William D Director 76,760 2025-04-18
1%
10 Clark David J Chief Medical Officer 17,878 2019-09-10
0%
11 Shah Nimesh 10 Percent Owner 10,358 2015-12-18
0%
12 Domain Associates 10 Percent Owner 10,358 2014-05-01
0%
13 Young Scott Chief Operating Officer 10,000 2016-03-18
0%
14 Alfieri Michael Principal Financial Officer 7,500 2026-03-19
0%
15 Clarke C. Boyd Director 6,083 2016-06-10
0%
16 Tulipano Stephen J Chief Financial Officer 5,410 2018-03-08
0%
17 Bronstein Ben Director 3,860 2025-06-12
0%
18 Phillips Gary M. Director 3,619 2025-06-12
0%
19 Miller-rich Nancy Director 2,413 2025-06-12
0%
20 Walker Neal Director 2,413 2025-06-12
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-27 Brady Todd C President and CEO RSU Award 632,318 - -
2026-03-19 Douglas Richard Director Informative Buy 70,000 $1.40 $98K
2026-03-18 Alfieri Michael Principal Financial Officer Informative Buy 5,000 $1.42 $7.1K
2025-08-13 Alfieri Michael Principal Financial Officer Informative Buy 2,500 $5.30 $13.25K
2025-08-11 Machatha Stephen Chief Development Officer Informative Sell 22,073 $5.15 $113.71K
2025-06-10 Miller-rich Nancy Director RSU Award 2,413 $2.69 $6.48K
2025-06-10 Bronstein Ben Director RSU Award 3,619 $2.69 $9.72K
2024-06-10 Bronstein Ben Director RSU Award 3,860 $2.69 $10.36K
2025-06-10 Walker Neal Director RSU Award 2,413 $2.69 $6.48K
2025-06-10 Joyce Martin Joseph Director RSU Award 1,689 $2.69 $4.53K
2025-06-10 Phillips Gary M. Director RSU Award 3,619 $2.69 $9.72K
2025-06-10 Douglas Richard Director RSU Award 1,689 $2.69 $4.53K
2025-04-17 Clark William D Director RSU Award 76,760 $2.19 $168.1K
2025-04-17 Clark William D Officer Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message